Back
AnaptysBio Vs. Black Diamond Therapeutics Industry Stock Comparison
Buy
64
ANAB
AnaptysBio
Last Price:
38.52
Seasonality Move:
26.98%
Sell
38
BDTX
Black Diamond Therapeutics
Last Price:
4.76
Seasonality Move:
-24.01%
Buy
64
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $38.51. The Score for ANAB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy, Sell or Hold?
- The current Black Diamond Therapeutics [BDTX] share price is $4.76. The Score for BDTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $38.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANAB is experiencing slight buying pressure.
BDTX Stock Price Chart
What is Black Diamond Therapeutics's stock price today?
-
The Black Diamond Therapeutics share price today is $4.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 57.43 | Buy |
| Chaikin Money Flow: | 128681 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.7 - 38.26) | Buy |
| Bollinger Bands (100): | (24.4 - 35.84) | Buy |
BDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 38.31 | Sell |
| Chaikin Money Flow: | 350174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.21 - 6.31) | Sell |
| Bollinger Bands (100): | (4.79 - 6.21) | Sell |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.87 | Buy |
| 20-day SMA: | 37.15 | Buy |
| 50-day SMA: | 35.57 | Buy |
| 200-day SMA: | 26.2 | Buy |
| 8-day EMA: | 37.66 | Buy |
| 20-day EMA: | 36.97 | Buy |
| 50-day EMA: | 34.68 | Buy |
| 200-day EMA: | 27.78 | Buy |
BDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.33 | Sell |
| 20-day SMA: | 5.73 | Sell |
| 50-day SMA: | 5.69 | Sell |
| 200-day SMA: | 4.78 | Sell |
| 8-day EMA: | 5.16 | Sell |
| 20-day EMA: | 5.47 | Sell |
| 50-day EMA: | 5.54 | Sell |
| 200-day EMA: | 4.85 | Sell |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.06 per share.
Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.57 per share, and a decrease next year of $0.14 per share.
AnaptysBio Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Black Diamond Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||